Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
28 Novembre 2023 - 11:22PM
Edgar (US Regulatory)
Filed Pursuant to Rule 433 under the Securities Act of 1933, as amended
Registration Statement No. 333-263051
Supplementing the Preliminary Prospectus Supplement, dated November 28, 2023
(To Prospectus dated February 25, 2022)
Zimmer Biomet Holdings, Inc.
Pricing Term Sheet
$500,000,000 5.350% Notes due 2028
November 28, 2023
The
information in this pricing term sheet (the Pricing Term Sheet) supplements the information in Zimmer Biomet Holdings, Inc.s preliminary prospectus supplement, dated November 28, 2023 (the Preliminary
Prospectus) and supersedes the information in the Preliminary Prospectus to the extent inconsistent with the information in the Preliminary Prospectus. Otherwise, this Pricing Term Sheet is qualified in its entirety by reference to the
Preliminary Prospectus. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Preliminary Prospectus.
|
|
|
Issuer: |
|
Zimmer Biomet Holdings, Inc. (the Company) |
|
|
Title of Securities: |
|
$500,000,000 5.350% Notes due 2028 (the Notes) |
|
|
Principal Amount: |
|
$500,000,000 |
|
|
Price to Public: |
|
99.965% |
|
|
Gross Proceeds: |
|
$499,825,000 |
|
|
Underwriting Discount: |
|
0.600% |
|
|
Net Proceeds (before expenses): |
|
$496,825,000 |
|
|
Maturity Date: |
|
December 1, 2028 |
|
|
Coupon: |
|
5.350% |
|
|
Yield to Maturity: |
|
5.358% |
|
|
Benchmark Treasury: |
|
4.875% UST due October 31, 2028 |
|
|
Benchmark Treasury Price; Yield: |
|
102-12 3⁄4 / 4.328% |
|
|
Spread to Benchmark Treasury: |
|
T + 103 basis points |
|
|
Interest Payment Dates: |
|
Semi-annually in arrears on December 1 and June 1 of each year, commencing on June 1, 2024 |
|
|
|
|
|
Redemption Provisions: |
|
Prior to November 1, 2028 (the Par Call Date), the Company may redeem the Notes at its option, in whole or in part,
at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:
(1) (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the
Notes matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate, plus 20 basis points less
(b) interest accrued to the date of redemption, and (2) 100% of the principal
amount of the Notes to be redeemed, plus, in either case, accrued and unpaid
interest thereon to the redemption date. On or after the Par Call Date, the Company
may redeem the Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to the redemption date. |
|
|
Repurchase at the Option of Holders upon a Change of Control Repurchase Event: |
|
If a Change of Control Repurchase Event occurs with respect to the Notes, the Company will be required to offer to repurchase the Notes at a repurchase price equal to 101% of their principal amount, plus accrued and unpaid interest
on the Notes to be repurchased to the date of repurchase, unless the Notes have been previously redeemed or called for redemption. |
|
|
CUSIP: |
|
98956P AX0 |
|
|
ISIN: |
|
US98956PAX06 |
|
|
Ratings*: |
|
Baa2 (Stable) / BBB (Stable) / BBB (Stable) |
|
|
Trade Date: |
|
November 28, 2023 |
|
|
Settlement Date**: |
|
December 1, 2023 (T+3) |
|
|
Joint Book-Running Managers: |
|
Barclays Capital Inc. Goldman Sachs &
Co. LLC Mizuho Securities USA LLC Morgan Stanley &
Co. LLC BNP Paribas Securities Corp. BofA Securities,
Inc. Citigroup Global Markets Inc. DNB Markets, Inc.
HSBC Securities (USA) Inc. J.P. Morgan Securities LLC
RBC Capital Markets, LLC SMBC Nikko Securities America,
Inc. |
|
|
|
Senior Co-Managers: |
|
TD Securities (USA) LLC UniCredit Capital
Markets LLC U.S. Bancorp Investments, Inc. |
|
|
Co-Managers: |
|
Academy Securities, Inc. CAVU Securities
LLC Loop Capital Markets LLC R. Seelaus & Co.,
LLC Siebert Williams Shank & Co., LLC |
|
|
Form of Notes: |
|
Global notes deposited with The Depository Trust Company |
|
|
Denominations: |
|
Minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof |
* |
A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision
or withdrawal by the assigning rating organization at any time. Each rating should be evaluated independently of any other rating. |
** |
Under Rule 15c6-1 under the Securities Exchange Act of 1934, as
amended, trades in the secondary market are required to settle in two business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes prior to the second business day before the
delivery of the Notes will be required to specify alternative settlement arrangements to prevent a failed settlement. Purchasers of the Notes who wish to trade Notes prior to their date of delivery hereunder should consult their own advisors.
|
This Pricing Term Sheet supplements the Preliminary Prospectus issued by the Company on November 28, 2023 relating to its
prospectus dated February 25, 2022, Registration Statement No. 333-263051.
The Company has filed a
registration statement (including a base prospectus) and the Preliminary Prospectus with the U.S. Securities and Exchange Commission (the SEC) for the offering to which this communication relates. Before you invest, you should
read the Preliminary Prospectus, the accompanying base prospectus in that registration statement, this Pricing Term Sheet and other documents the Company has filed with the SEC for more complete information about the Company and this offering. You
may obtain these documents for free by visiting EDGAR on the SECs website at www.sec.gov. Alternatively, the Company, any underwriter or any dealer participating in the offering will arrange to send you the Preliminary Prospectus, the
final prospectus supplement (when available) and the accompanying base prospectus if you request it by calling Barclays Capital Inc. at (888) 603-5847, Goldman Sachs & Co. LLC at (866) 471-2526, Mizuho Securities USA LLC at (866) 271-7403 and Morgan Stanley & Co. LLC at (866) 718-1649.
Grafico Azioni Zimmer Biomet (NYSE:ZBH)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Zimmer Biomet (NYSE:ZBH)
Storico
Da Set 2023 a Set 2024